Top 10 Overjet Alternatives: How to Choose in 2026

Comparing Overjet? See how it stacks up against Pearl, VideaHealth, Denti.AI, and 7 more dental AI alternatives, including pricing, FDA clearances, and reviews.

Georgey JacobGeorgey Jacob|
37 min read
Top 10 Overjet Alternatives: How to Choose in 2026

The single decision that matters most when comparing Overjet to its alternatives is not which vendor has the flashiest AI demo, but which clinical workflow you actually need automated. Pearl, VideaHealth, Denti.AI, and Velmeni are the true head-to-head competitors for chairside 2D pathology detection on bitewing and periapical film. Diagnocat is built specifically for 3D CBCT scans. Orca Dental AI and Dental Monitoring solve narrower, different clinical problems (cephalometric analysis and remote ortho monitoring) rather than caries or perio detection. Adravision is the only alternative attempting Overjet's payer-facing claims angle, at a vastly smaller funding stage. And KELLS and Zentist solve different jobs entirely (consumer discount membership and revenue-cycle billing) despite surfacing in some Overjet alternative searches. Match the tool to the workflow first, then compare price and FDA clearance depth within that narrower set.

TL;DR

Ranked by how closely each product actually competes with Overjet's core AI-powered imaging platform, not by funding size alone.

  1. Pearl (Second Opinion): one broad FDA clearance covering caries, bone loss, calculus, and more, at a published flat monthly price.
  2. VideaHealth: Harvard/MIT-founded chairside detection AI with the deepest named DSO customer base (Heartland Dental, dentalcorp).
  3. Denti.AI: the only vendor here cleared for panoramic-film disease detection specifically, alongside auto-charting.
  4. Velmeni (V4D): a newer, thinly-documented entrant whose own FDA clearance pathway cites an Overjet filing as its predicate.
  5. Diagnocat: a CBCT-specific specialist, the direct comparison point for Overjet's own CBCT Assist clearance.
  6. Orca Dental AI (CephX): a narrower, different clinical use case: AI-assisted orthodontic cephalometric analysis, not general pathology detection.
  7. Adravision: an early-stage, YC-backed platform targeting clinics, DSOs, and payers at once, at roughly $230K raised.
  8. Dental Monitoring: a different workflow altogether: AI-based remote patient monitoring between orthodontic visits, not chairside imaging.
  9. KELLS: a consumer discount-membership and telehealth-triage platform, not enterprise imaging or claims AI.
  10. Zentist: dental revenue-cycle-management automation for DSOs, an adjacent billing category rather than imaging AI.

How We Evaluated These 10 Overjet Alternatives

With these 7 major criteria we have carefully evaluated every alternative, so you can choose the better Overjet alternative for your practice or DSO.

  1. Clinical or functional scope: what pathology, condition, or workflow the AI actually detects or automates.
  2. FDA clearance status, and how independently verifiable the clearance count actually is against FDA.gov.
  3. Payer-side or claims-facing capability, the pillar of Overjet's own platform that most alternatives do not attempt.
  4. Integration depth with practice management and imaging systems, by name where the vendor discloses it.
  5. Company maturity: funding raised, named customers, and years actually in market.
  6. Pricing transparency: a published price versus a "contact vendor" model.
  7. Independent review-platform coverage on G2 and Capterra, and whether that coverage is thin or contradictory.

Comparison of Top 10 Overjet Alternatives

CompanyBest fitTypeFDA clearancePricingReview
Pearl (Second Opinion)Practices wanting one broad clearance across many findingsChairside imaging AI1 broad clearance (K210365, third-party-sourced)$299/month (per Capterra)3.5 · 1 · G2; 4.3 · 4 · Capterra
VideaHealthDSOs wanting deep clinical validation and named enterprise customersChairside imaging AIAt least 3 clearances (1 confirmed on FDA.gov)Not publishedNo score found on G2 or Capterra
Denti.AIPractices wanting panoramic-film detection plus auto-chartingChairside imaging AI2 clearances (vendor press, not independently re-verified)Not published ($49/month per one third-party site, unconfirmed)No score found for the imaging product (4.9 · 8 · Capterra is for its separate Voice product)
Velmeni (V4D)Practices open to a newer, less-documented entrantChairside imaging AI2 clearances per an industry trackerNot foundNo score found on G2 or Capterra
DiagnocatPractices whose priority is 3D CBCT analysis specifically3D/CBCT imaging AI1 clearance claimed, K-number not disclosedNot foundNo score found on G2 or Capterra
Orca Dental AI (CephX)Orthodontic practices needing cephalometric analysis specificallyNiche specialist AI1 clearance (third-party tracker only)Not foundNo score found on G2 or Capterra
AdravisionEarly adopters wanting a payer-facing angle at small scaleEarly-stage payer-facing AINone foundNot foundNo score found on G2 or Capterra
Dental MonitoringOrtho practices wanting between-visit remote monitoringNiche specialist AI (ortho)Not applicable (different regulatory profile)Not published0.0 · 0 · Capterra
KELLSConsumers wanting a discounted dentist network, not a practice toolAdjacent category (consumer)None found / not applicableFree/Basic; Premium $99/yr; Complete $149/yrNo score found on G2 or Capterra
ZentistDSOs wanting billing/claims operations automation, not imaging AIAdjacent category (RCM)None found / not applicableNot publishedNo score found on G2 or Capterra

Company order matches the TL;DR ranking above. "Not published" and "not found" are stated as facts, not implied reasons; see each profile for sourcing detail.

What Is AI-Powered Dental Imaging Software?

AI-powered dental imaging software uses machine learning models, most FDA-cleared, to scan X-rays or CBCT images and flag caries, bone loss, calculus, and periapical lesions, helping dentists catch pathology sooner and document findings for treatment planning and insurance claim decisions faster.

How Big Is the AI-Powered Dental Imaging Category?

We could not find a dedicated market-size or revenue report specific to AI-powered dental imaging and pathology-detection software, as distinct from the much broader "dental AI" or "AI in dentistry" category that also includes scheduling software, patient chatbots, and generic practice-management tools. Broader "AI in dentistry" market reports exist, but folding them in here would overstate the size of the narrower chairside-imaging-detection and payer-claims-AI category this document actually covers, so we are stating the gap plainly rather than presenting an adjacent number as if it answered the question. What is independently verifiable instead: the funding raised by named vendors in this list (Overjet's stated $130M+, Pearl's $58M Series B, VideaHealth's $40M Series B), and the FDA's own public 510(k) database, which is the most reliable proxy for how active this specific category actually is.

The 10 Overjet Alternatives, in Detail

1. Pearl (Second Opinion)

Best for: practices that want one broad FDA clearance covering many findings at once, at a published flat price.

Pearl, marketed as hellopearl.com, is a chairside AI imaging platform whose flagship product, Second Opinion, holds a single FDA clearance (K210365, cleared around March 2022 per third-party trackers, not independently re-verified against FDA.gov this pass) covering caries, periapical radiolucencies, calculus, crown and filling findings, implants, bridges, root canals, and restoration-margin discrepancies on bitewing and periapical film for patients age 16 and older.

How it delivers pathology detection

Second Opinion runs against a practice's existing 2D X-ray images and returns findings across all covered conditions from one clearance, rather than requiring a separate clearance per finding type, which is how Overjet's own nine clearances are structured.

Highlighting featuresOne clearance covers caries, bone loss, calculus, and 5+ other finding types · 40+ claimed system integrations across imaging and PMS platforms · Flat published monthly price with a free trial · $58M Series B (Aug 2024), led by Left Lane Capital
Clinical/functional scopeChairside 2D pathology detection: caries, bone loss, calculus, root canals, implants, restoration-margin discrepancies
FDA clearanceK210365, "Second Opinion," ~March 2022 (per third-party trackers, not independently re-verified against FDA.gov)
Payer-facing capabilityNone found; provider-side detection only
IntegrationsImaging: DEXIS, Carestream, Romexis, Sidexis, Apteryx XVWeb, MiPACS, SOTA Cloud, Tab32, Vatech, Medit. PMS: Open Dental, Eaglesoft, Curve, Dentally, Dentrix, Planet DDS, Patterson Dental, CareStack, Denticon, ClearDent
Funding and maturity$58M Series B, Aug 2024 (Left Lane Capital lead, with Smash Capital, Alpha Partners, Craft Ventures, Neotribe Ventures); founder/CEO Ophir Tanz
Pricing$299/month flat rate, free trial available (per Capterra, not confirmed on Pearl's own site)
Review3.5 · 1 · G2; 4.3 · 4 · Capterra

Strengths

  • One clearance covers a wide range of findings, reducing the "which condition is this cleared for" question other vendors force
  • Pricing is actually published, a rarity in this category
  • The largest claimed integration list among the chairside-detection competitors

Limits

  • No payer-facing claims product found, unlike Overjet's Dental Clarity Network
  • Review coverage is thin: 1 G2 review and 4 Capterra reviews for a company that claims the "largest investment ever in dental AI"
  • Some Capterra reviewers note false-positive detections despite the broad clearance

Who it's for: practices and small DSOs that want one vendor, one clearance, and a published price rather than a custom quote. Who should skip it: any DSO or payer that specifically needs claims-review or claims-decisioning tooling, since Pearl does not offer one.

2. VideaHealth

Best for: DSOs wanting the deepest clinical validation and the largest named enterprise customer base among the alternatives.

VideaHealth (videahealth.io), founded in 2018 by CEO Florian Hillen and described by the company as "born from Harvard and MIT AI research," builds FDA-cleared chairside detection AI across three named product lines: Videa Caries Assist, Videa Dental Assist (30+ algorithms, including pediatric caries detection for patients age 3 and up, cleared January 3, 2024), and Videa Perio Assist (K223296, independently confirmed on FDA.gov, cleared February 6, 2023).

How it delivers pathology detection

VideaHealth's models run against 2D X-ray images across a broad set of findings and are positioned around a specific vendor-reported accuracy claim: a 43% reduction in missed cavities and a 15% average reduction in false positives, both stated by the company rather than independently corroborated in this pass.

Highlighting features30+ detection algorithms including pediatric caries (age 3+) · Vendor-cited 43% reduction in missed cavities, 15% reduction in false positives · Named enterprise customers: Heartland Dental, dentalcorp · $40M Series B, Jan 2025, led by Threshold Ventures
Clinical/functional scopeChairside 2D detection across caries, perio, and general dental findings
FDA clearanceAt least 3 clearances: Videa Caries Assist (~May 2022), Videa Dental Assist (Jan 3, 2024), Videa Perio Assist (K223296, Feb 6 2023, independently confirmed on FDA.gov)
Payer-facing capabilityNone found; provider-side detection only
IntegrationsNot itemized by name in available sources
Funding and maturity$40M Series B, Jan 28 2025 (Threshold Ventures lead, with Avenir, BAM Corner Point, Spark Capital, Zetta Venture Partners, Pillar VC); total funding to date not disclosed
PricingNot published, not found
ReviewNo score found on G2 or Capterra

Strengths

  • The largest named enterprise customer roster of any alternative on this list (Heartland Dental, dentalcorp)
  • A pediatric-specific caries clearance (age 3+), a narrower use case most competitors do not name
  • One clearance (Perio Assist) independently confirmed directly on FDA.gov, not just via a press release

Limits

  • No independent review score exists on either G2 or Capterra, a real data gap for a well-funded vendor
  • Pricing is not published anywhere found
  • No payer-facing claims product, so it does not compete with Overjet's Dental Clarity Network side

Who it's for: multi-location DSOs that want a vendor with named enterprise references and pediatric-specific coverage. Who should skip it: buyers who need to see independent review scores before committing, since none currently exist.

3. Denti.AI

Best for: practices wanting panoramic-film disease detection specifically, alongside automated charting.

Denti.AI (denti.ai), founded in 2017 in Toronto by CEO Dmitry Tuzoff, runs two linked FDA-cleared product lines: Denti.AI Auto-Chart (tooth detection, numbering, and charting automation, cleared December 13, 2022, the first FDA-cleared AI dental auto-charting software) and Denti.AI Detect (caries, bone loss, and periapical lesion detection on both panoramic and intraoral film, cleared October 25, 2023). The company also offers a separate AI perio-charting and scribe product, Denti.AI Voice.

How it delivers pathology detection

Denti.AI Detect is, by the vendor's own account, the only company cleared for all three major dental concerns (caries, bone loss, periapical lesions) and the first cleared for panoramic-film disease detection specifically, a film type most competitors do not cover. A vendor-cited study reports 26% extra treatment opportunities identified across 24 dentists.

Highlighting featuresFirst FDA-cleared AI auto-charting software (Auto-Chart) · Only vendor cleared for panoramic-film disease detection specifically (Detect) · Vendor-cited 70% reduction in charting time/effort · 10,000+ dental professionals served, vendor-claimed
Clinical/functional scopeAuto-Chart: tooth detection, numbering, charting automation. Detect: caries, bone loss, periapical lesions on panoramic AND intraoral film
FDA clearance2 clearances: Auto-Chart (Dec 13 2022), Detect (Oct 25 2023); both via vendor press releases, not independently re-verified against FDA.gov this pass
Payer-facing capabilityNone found; provider-side detection and charting only
Integrations"10+ practice management systems" claimed, not itemized by name
Funding and maturityFounders and funding amount not disclosed in available sources; 10,000+ professionals served, vendor-claimed
PricingNot disclosed by vendor; one third-party review site (review.dental) headlines it as "the price disruptor at $49," explicitly a third-party claim, not vendor-confirmed
Review4.9 · 8 · Capterra, but that score is for the separate Denti.AI Voice/scribe product, not for Detect, the imaging-AI product profiled here. No independent score found for Detect itself

Strengths

  • Panoramic-film disease detection is a genuine point of differentiation most competitors do not offer
  • One clearance covers three major concerns at once (caries, bone loss, periapical lesions)
  • Bundles charting automation and imaging detection under one vendor relationship

Limits

  • Neither K-number was independently re-verified against FDA.gov this pass, unlike Overjet's and VideaHealth's partial confirmation
  • The widely cited "$49/month" price is a third-party claim, not something Denti.AI publishes itself
  • The 4.9/5 Capterra score belongs to Denti.AI Voice, not to the Detect imaging product being compared to Overjet here

Who it's for: practices that rely heavily on panoramic film and want charting automation bundled in. Who should skip it: buyers pricing decisions on that widely repeated "$49/month" figure, since it is not vendor-confirmed.

4. Velmeni (V4D)

Best for: practices open to a newer, thinly documented entrant with a real FDA clearance.

Velmeni's V4D ("Velmeni for Dentists") is an AI tool that detects cavities, fillings, and implants from X-rays, cleared by the FDA in September 2024 and also approved in Canada and New Zealand. It is the thinnest-documented vendor in this list: founders, funding, pricing, reviews, and named integrations were not found anywhere in research.

How it delivers pathology detection

An independent 510(k) tracker (Innolitics) notes Velmeni Inc. holds 2 total clearances, with V4D cleared under a Predetermined Change Control Plan that cites Overjet's own K222746 clearance as a predicate device, meaning Velmeni's clearance pathway literally referenced a prior Overjet filing.

Highlighting featuresDetects cavities, fillings, and implants from X-rays · Cleared in the US, Canada, and New Zealand · FDA clearance pathway cites an Overjet clearance as predicate device
Clinical/functional scopeChairside 2D detection: cavities, fillings, implants
FDA clearance2 clearances per an independent tracker (Innolitics); V4D cleared Sept 2024 under a Predetermined Change Control Plan citing Overjet's K222746 as predicate
Payer-facing capabilityNot found
IntegrationsNot found
Funding and maturityFounders and funding not found anywhere in research; the thinnest-documented vendor in this set
PricingNot found
ReviewNo score found on G2 or Capterra

Strengths

  • A genuine, multi-market FDA/regulatory clearance (US, Canada, New Zealand), not merely a claim
  • A real, current alternative rather than an abandoned or rebranded product

Limits

  • No founder, funding, pricing, or integration information could be found anywhere in research
  • Its own clearance pathway depends on an Overjet filing as predicate device, a direct dependency worth knowing before treating it as fully independent
  • No independent review score exists on G2 or Capterra

Who it's for: buyers comfortable evaluating an emerging, small vendor directly rather than relying on published reviews or funding history. Who should skip it: DSOs that require vendor financial stability or reference customers as a purchasing condition.

5. Diagnocat

Best for: practices whose priority is 3D CBCT analysis specifically, not general 2D chairside detection.

Diagnocat (diagnocat.com) is an AI platform built specifically for CBCT (3D) visualization and analysis, positioned around the tagline "CBCT as easy as ABC," plus patient-communication reporting tools. The company states it had already served dental professionals in more than 50 countries before its US launch. A founder is referenced in company materials as Dr. Alex Sanders, though a specific title was not stated in available sources.

How it delivers CBCT analysis

Diagnocat states it has obtained US FDA clearance in a company announcement, though the specific K-number and exact decision date were not disclosed in available page content. This makes it the direct comparison point for Overjet's own CBCT Assist clearance (K251514, Dec 2025) specifically, not for Overjet's broader 2D platform.

Highlighting featuresPurpose-built for 3D CBCT scan analysis, not general 2D film · Patient-communication reporting included · Already serving professionals in 50+ countries before US launch
Clinical/functional scope3D CBCT visualization and analysis specifically
FDA clearanceUS clearance stated by the company; specific K-number and decision date not disclosed in available sources
Payer-facing capabilityNot found
IntegrationsNot found
Funding and maturityNot found; a founder is referenced as Dr. Alex Sanders, role not specified
PricingNot found
ReviewNo score found on G2 or Capterra

Strengths

  • The only vendor on this list built specifically for 3D CBCT rather than 2D film
  • An established international footprint (50+ countries) before entering the US market
  • Patient-communication reporting bundled alongside the diagnostic output

Limits

  • The specific FDA K-number and clearance date are not disclosed anywhere found, unlike most other vendors on this list
  • Funding, pricing, and independent review scores are not found anywhere in research
  • It does not address 2D chairside detection, so it cannot replace a Pearl, VideaHealth, or Denti.AI purchase on its own

Who it's for: practices and imaging centers whose primary volume is CBCT scans rather than 2D bitewing/periapical film. Who should skip it: practices without meaningful CBCT volume, since 2D detection is not this product's focus.

6. Orca Dental AI (CephX)

Best for: orthodontic practices needing cephalometric analysis specifically, not caries or perio detection.

Orca Dental AI, an Israeli startup, builds CephX, an AI-assisted cephalometric analysis tool for orthodontic X-rays, covering diagnosis, treatment planning, and simulation for patients age 14 and older. This is a narrower, genuinely different clinical use case than the general caries, perio, and bone-loss detection most of this list competes on.

How it delivers cephalometric analysis

CephX was cleared under that name on January 28, 2024, per an independent tracker not independently re-verified against FDA.gov this pass. We are presenting this vendor explicitly as a different clinical use case, a niche specialist, not a head-to-head Overjet substitute.

Highlighting featuresAI-assisted cephalometric diagnosis, treatment planning, and simulation · For orthodontic X-rays specifically, patients age 14+ · Israeli startup per a startup-directory listing
Clinical/functional scopeOrthodontic cephalometric analysis, a different workflow than caries/perio/bone-loss detection
FDA clearanceCephX cleared Jan 28 2024 per an independent tracker, not independently re-verified against FDA.gov
Payer-facing capabilityNot found
IntegrationsNot found
Funding and maturityFounders and funding not found; only aggregator profile pages surfaced
PricingNot found
ReviewNo score found on G2 or Capterra

Strengths

  • A real, named FDA clearance for a specific, well-defined orthodontic use case
  • Fills a niche (cephalometric analysis) that none of the general chairside-detection vendors on this list address

Limits

  • Does not compete on caries, perio, or bone-loss detection at all, the core use case most buyers researching "Overjet alternatives" actually want
  • Founders, funding, pricing, and reviews were not found in available sources
  • The FDA clearance date was not independently re-verified against FDA.gov this pass

Who it's for: orthodontic practices specifically needing cephalometric AI, as a complement to, not a replacement for, a general chairside detection tool. Who should skip it: general dental practices looking for caries or perio detection, since that is not what CephX does.

7. Adravision (Adra)

Best for: early adopters wanting a vendor that explicitly targets clinics, DSOs, and payers at once.

Adravision (adra.ai), a Y Combinator S21 company founded in 2021 in Atlanta, is one of the very few vendors on this list besides Overjet itself to explicitly target three segments at once: dental clinics, DSOs, and the insurance/payer sector. No FDA 510(k) clearance was found for this vendor, so it should be treated as not FDA-cleared unless the vendor states otherwise.

How it delivers payer-facing claims support

Adravision's positioning is the closest match on this list to Overjet's own payer-side ambition, but at a vastly smaller scale: roughly $230,000 total raised, most recently a Seed-II round of approximately $100,000, against Overjet's stated $130 million-plus raised.

Highlighting featuresTargets clinics, DSOs, and payers all at once · Y Combinator S21 batch · Founded 2021, Atlanta, GA
Clinical/functional scopeNot detailed in available sources; positioned around the payer/claims angle rather than a named detection algorithm list
FDA clearanceNone found; treat as not FDA-cleared unless the vendor states otherwise
Payer-facing capabilityExplicitly targets the payer/insurance sector, the closest match on this list to Overjet's own Dental Clarity Network ambition
IntegrationsNot found
Funding and maturityApproximately $230K total raised, most recent round approximately $100K (Seed-II stage); an early-stage, watch-list name
PricingNot found
ReviewNo score found on G2 or Capterra

Strengths

  • One of only two vendors in this entire list (with Overjet itself) explicitly targeting the payer side
  • A legitimate YC-backed startup with a clear three-segment go-to-market thesis

Limits

  • No confirmed FDA clearance, unlike every chairside-detection vendor on this list
  • At roughly $230K raised, its scale is a small fraction of Overjet's $130 million-plus
  • Pricing, integrations, and reviews were not found anywhere in research

Who it's for: early adopters and innovation-minded buyers comfortable evaluating an emerging, small vendor with a genuine payer-side thesis. Who should skip it: buyers who require an FDA-cleared product or an established funding history before purchase.

8. Dental Monitoring

Best for: orthodontic practices wanting AI-based remote monitoring between patient visits, a different workflow entirely.

Dental Monitoring (dental-monitoring.com), founded in 2014 in Paris by Philippe Salah (CEO), Armelle Coquart, and Emmanuel Salah, is a 501-1,000 employee company (per Crunchbase) whose AI monitors orthodontic treatment progress between visits: patients use a mobile app to send images, and the AI flags progress and compliance for the clinician.

How it delivers remote monitoring

This is a fundamentally different workflow from Overjet's chairside pathology detection or payer claims analytics, and we are framing it explicitly as a different use case (orthodontic remote monitoring), not a like-for-like substitute for Overjet's imaging platform.

Highlighting featuresPatient mobile app sends images between orthodontic visits · AI flags treatment progress and compliance for the clinician · 501-1,000 employees (Crunchbase band) · Lead investor: Lazard Elaia Capital
Clinical/functional scopeRemote, between-visit orthodontic treatment monitoring, not chairside pathology detection
FDA clearanceNot applicable; a different regulatory profile than chairside imaging-detection AI
Payer-facing capabilityNot found
IntegrationsNot found
Funding and maturityLead investor Lazard Elaia Capital; total amount not disclosed; founded 2014, Paris, France
PricingContact vendor for pricing; no free trial
Review0.0 · 0 · Capterra

Strengths

  • A mature, established company (founded 2014, 501-1,000 employees) with a clear and specific use case
  • Solves a real gap (between-visit monitoring) that chairside detection tools do not address at all

Limits

  • Zero Capterra reviews despite the company's scale, an unusual gap for a business this size
  • No published pricing and no free trial, unlike several smaller competitors on this list
  • Does not perform caries, perio, or bone-loss detection at all, so it cannot substitute for Overjet's core imaging function

Who it's for: orthodontic practices specifically wanting remote, between-visit patient monitoring. Who should skip it: anyone searching for a chairside pathology-detection or payer-claims alternative to Overjet, since this solves a different problem entirely.

9. KELLS

Best for: consumers wanting a discounted dentist network and virtual triage, not a practice, DSO, or payer buying an imaging or claims platform.

KELLS (getkells.com), founded in 2018 in Long Island City, NY, by co-founder and COO Kevin Duffy-Acevedo, is a consumer membership platform, explicitly not dental insurance, offering AI-powered virtual triage and checkups plus access to a discounted direct-pay dentist network the company claims covers 70,000-plus dentists nationwide. This is a different market segment than every other vendor on this list, and we are flagging that prominently rather than presenting it as a like-for-like substitute.

How it delivers consumer triage

KELLS' only feature that resembles Overjet's category at all is Treatment Validation, an AI-assisted second-opinion feature on proposed treatment plans. The rest of the product, membership tiers, a discount dentist network, and consumer telehealth triage, is a consumer discount-membership and telehealth business, not enterprise imaging or claims-decisioning AI sold to practices, DSOs, or payers.

Highlighting featuresAI-powered virtual triage and checkups for consumers · 70,000+ dentist discount network claimed · Treatment Validation: AI-assisted second opinions on proposed treatment plans · Three tiers: Free/Basic, Premium, Complete
Clinical/functional scopeConsumer-facing triage and treatment-plan second opinions, not chairside imaging AI or payer claims decisioning
FDA clearanceNone found; not applicable to this product category
Payer-facing capabilityNone; explicitly "not dental insurance"
IntegrationsNot found; consumer-facing product, not a PMS/imaging integration
Funding and maturityAngel-stage funding; investor R/GA Ventures; total not disclosed; founded 2018
PricingFree/Basic tier; Premium $99/year; Complete $149/year ("25-85% savings on procedures," vendor-stated)
ReviewNo score found on G2 or Capterra

Strengths

  • A large claimed discount-dentist network (70,000+) for consumers seeking direct-pay savings
  • Published, transparent consumer pricing tiers, unlike most B2B vendors on this list

Limits

  • This is a consumer product, not something a practice, DSO, or payer purchases as an imaging or claims platform
  • No FDA clearance and no chairside imaging-detection capability at all
  • Surfaces in some "Overjet alternative" searches despite serving a different buyer and a different job entirely

Who it's for: individual consumers wanting a discounted dentist network and virtual triage. Who should skip it: practices, DSOs, or payers evaluating chairside imaging AI or claims-decisioning platforms, since KELLS is not that product.

10. Zentist

Best for: DSOs wanting revenue-cycle-management automation, a different job than imaging AI or payer claims decisioning.

Zentist (zentist.io) provides dental revenue-cycle-management automation for DSOs: automated claims submission, posting, and accounts-receivable follow-up. This is billing and claims operations automation, not imaging AI and not the payer-side claims-decisioning AI that Overjet's ReviewPASS and Dental Clarity Network provide.

How it delivers revenue-cycle automation

Zentist automates the operational mechanics of getting claims submitted, posted, and followed up on for DSOs. It shares the word "AI" and the word "claims" with Overjet's marketing language, but the underlying job, billing operations versus clinical detection and claims-decisioning, is different, and we are framing that explicitly rather than presenting it as a head-to-head Overjet substitute.

Highlighting featuresAutomated claims submission for DSOs · Automated payment posting · Automated accounts-receivable follow-up
Clinical/functional scopeNone; this is billing and RCM operations automation, not clinical imaging or pathology detection
FDA clearanceNone found / not applicable; not a clinical device
Payer-facing capabilityAutomates the DSO side of claims operations; does not perform payer-side claims-decisioning the way Overjet's ReviewPASS/Dental Clarity Network does
IntegrationsNot found
Funding and maturityFounders and funding not found in available sources
PricingNot published; enterprise RCM pricing is typically custom-quoted
ReviewNo score found on G2 or Capterra

Strengths

  • Addresses a real, costly DSO pain point (claims submission, posting, A/R follow-up) that none of the imaging-AI vendors on this list touch
  • Purpose-built for DSO-scale billing operations rather than a general small-practice tool

Limits

  • Does no imaging analysis and no chairside pathology detection at all
  • Its claims-automation focus is operational (submission, posting, A/R), not the payer-side claims-decisioning Overjet's ReviewPASS performs
  • Founders, funding, and pricing were not found anywhere in research

Who it's for: DSOs specifically looking to automate claims submission, posting, and A/R follow-up as a billing operations upgrade. Who should skip it: anyone searching for imaging AI or payer-side claims-decisioning to replace Overjet, since Zentist does neither.

Top 10 Overjet Alternatives Pricing in Detail

Where a vendor states a specific accuracy or time-savings figure on its own site, we show that figure alongside pricing rather than dropping it, since it is the closest thing to a stated value claim most of these vendors publish.

CompanyCommercial modelPublished priceVendor's own performance claim (as stated)
PearlFlat monthly subscription (per Capterra, not vendor-confirmed on Pearl's own site)$299/month (per Capterra), free trial availableNo vendor-published accuracy or time-savings percentage found
VideaHealthNot published, contact vendorNot published"43% reduction in missed cavities" and "15% average reduction in false positives" (vendor-stated)
Denti.AINot published for Detect; Voice/scribe product priced separatelyNot published ("$49/month" per one third-party review site, not vendor-confirmed)"70% reduction in time/effort" for Auto-Chart; "26% extra treatment opportunities" across 24 dentists for Detect (vendor-stated)
Velmeni (V4D)Not foundNot foundNot found
DiagnocatNot foundNot foundNo performance percentage found; "CBCT as easy as ABC" positioning only
Orca Dental AI (CephX)Not foundNot foundNot found
AdravisionNot publishedNot foundNot found
Dental MonitoringContact vendor for pricing (per Capterra)Not published, no free trialNot found
KELLSConsumer membership tiersFree/Basic; Premium $99/year; Complete $149/year ("25-85% savings on procedures," vendor-stated)"70,000+ dentists nationwide" network size (vendor-stated)
ZentistEnterprise RCM, typically custom-quotedNot publishedNot found

"Not found" means no figure surfaced in research, vendor or third-party. This is not the same as "$0" or "free."

Not All Overjet Alternatives Are the Same Kind of Tool

Five of these ten vendors compete head-to-head with Overjet on chairside 2D pathology detection. The rest solve a genuinely different problem, and treating them as interchangeable is the single most common mistake in searches for this keyword.

CategoryWhat it isWho is in itWhat to ask
Chairside/clinical imaging AIFDA-cleared AI that reads 2D X-ray film for caries, bone loss, calculus, and periapical findings, the true head-to-head competitor set for Overjet's core provider-side productPearl · VideaHealth · Denti.AI · VelmeniWhich specific pathologies are covered under one clearance versus several, and on which film types?
3D/CBCT-specific imaging AIAI built specifically for 3D CBCT scan visualization and analysis, rather than 2D chairside filmDiagnocatDoes it also handle 2D films, or is it CBCT only?
Niche/specialist clinical AIAI for a narrower clinical workflow, cephalometric analysis or remote between-visit ortho monitoring, that does not compete head-to-head with caries or perio detectionOrca Dental AI (CephX) · Dental MonitoringDoes this actually replace or complement a chairside detection tool?
Early-stage payer-facing AIAn AI-native platform targeting clinics, DSOs, and payers at once, the closest thesis match to Overjet's own payer-side ambition, at a far earlier funding stageAdravisionWhat is actually live in production today versus on the roadmap?
Adjacent-but-different categoryTools that surface in "Overjet alternative" searches but solve a different problem: consumer discount membership, or revenue-cycle billing automationKELLS · ZentistDoes this tool perform imaging AI or claims-decisioning AI at all, or something else entirely?

Which Overjet Alternative Fits Your Practice Type

This table genuinely rules some vendors out for some segments. A table where one vendor wins every row is not a credible fit assessment.

Practice/organization typeChooseSkip
Solo or small general practice wanting one clearance and a published pricePearl, for its single broad clearance and flat published rateVideaHealth or Denti.AI, since neither publishes pricing
Multi-location DSO wanting named enterprise referencesVideaHealth, for its Heartland Dental and dentalcorp customer referencesVelmeni or Orca Dental AI, since neither discloses named customers
Practice relying heavily on panoramic filmDenti.AI, the only vendor cleared for panoramic-film disease detection specificallyPearl or VideaHealth, whose clearances are not described as panoramic-specific
Imaging center or practice with significant CBCT volumeDiagnocat, purpose-built for 3D CBCT analysisPearl, VideaHealth, or Denti.AI, all built around 2D film
Orthodontic-only practiceOrca Dental AI for cephalometric analysis, or Dental Monitoring for between-visit remote monitoring, depending on which workflow you needAny general chairside caries/perio detection vendor, since neither replaces the other
DSO or group evaluating a payer-facing claims angleAdravision, at an early stage, or Overjet itself, at a far larger scaleKELLS or Zentist, neither of which performs payer-side claims-decisioning
DSO whose actual pain point is billing and A/R, not imagingZentist, for revenue-cycle-management automationAny imaging-detection vendor on this list, since none of them touch billing operations
Individual consumer wanting a discounted dentist networkKELLSAny vendor on this list sold to practices, DSOs, or payers, since KELLS is the only consumer-facing product here

If your practice's actual need is general chairside caries and perio detection, the real Overjet head-to-head set is Pearl, VideaHealth, Denti.AI, and Velmeni. Every other row above is a different tool solving a different problem, not a weaker version of the same one.

FDA Clearance Claims: What Is Actually Corroborated

Independent FDA-clearance-count verification for this category is inconsistent across every source, including the vendor's own PR. This table states what could be independently confirmed on FDA.gov versus what could not, rather than repeating any single vendor's self-reported count.

VendorBest-confirmed clearance countVendor/third-party claimNote
Overjet9, independently confirmed directly against FDA.gov's 510(k) database (K210187 through K253930, 2021-2026)Overjet's own PR calls its Dec 2025 clearance the "10th"; a third-party review site claims "7"A three-way discrepancy across the vendor, a reviewer, and our own independent count
Pearl1 broad clearance (K210365, "Second Opinion")Same, per third-party trackersNot independently re-verified against FDA.gov this pass
VideaHealthAt least 31 (Videa Perio Assist, K223296) independently confirmed on FDA.gov; the other 2 via press releases and trackersPartial independent confirmation, better than most vendors on this list
Denti.AI2 (Auto-Chart, Detect)Vendor press releasesNot independently re-verified against FDA.gov this pass
Velmeni2, per an independent tracker (Innolitics)SameOne clearance cites an Overjet filing (K222746) as predicate device
Diagnocat1 claimedCompany announcementK-number and exact decision date not disclosed
Orca Dental AI (CephX)1Third-party tracker onlyNot independently re-verified against FDA.gov
AdravisionNone foundNot applicableTreat as not FDA-cleared unless the vendor states otherwise
Dental MonitoringNot applicableNot applicableA different regulatory profile than imaging-detection AI
KELLSNone foundNot applicableNot applicable to this consumer product category

8 Things Worth Checking Before You Choose Any Overjet Alternative

What to checkWhy it matters
CareStack is not an Overjet competitorCareStack's own "AI Suite" runs on Overjet's FDA-cleared AI under a named "Smart Dental Platform" partnership since April 2025. It is a distribution partner, not an independent alternative, and should not appear on a genuine "Overjet alternatives" list
Overjet's own FDA clearance count is disputed across three sources9 independently confirmed on FDA.gov, Overjet's own PR calling its Dec 2025 clearance the "10th," and a third-party review site citing "7." Ask which number a source actually verified before repeating it
Review-platform coverage across this entire category is thinEven Overjet, the best-funded vendor here, has just 1 review on each of G2 and Capterra, and the two scores contradict each other (0.0/5 versus 5.0/5). Do not assume mature-SaaS-category review volume anywhere in this space
Denti.AI's 4.9/5 Capterra score belongs to a different productThat score is for Denti.AI Voice, a scribe product, not for Denti.AI Detect, the imaging-AI product actually being compared to Overjet
KELLS is a consumer product, not a practice or DSO toolIt is a discount-membership and telehealth-triage platform, explicitly "not dental insurance," despite surfacing in some Overjet-alternative searches
Zentist is billing automation, not imaging AIIt automates claims submission, posting, and A/R follow-up for DSOs, a different job than pathology detection or payer-side claims decisioning, despite overlapping marketing language
Velmeni's own FDA clearance pathway cites an Overjet filing as predicate deviceThis is a direct regulatory dependency worth knowing before treating Velmeni as a fully independent competitor
Several vendors on this list have no independently confirmed founder, funding, or pricing informationVelmeni, Diagnocat, Orca Dental AI, and Adravision all have real documentation gaps. Ask directly rather than assuming the gap means something specific

A 12-Question Checklist Before You Choose Any Overjet Alternative

  1. Which specific pathologies or findings does the AI detect, and on which film types (bitewing, periapical, panoramic, CBCT)?
  2. Is the clearance a single broad FDA filing or several narrower ones, and can you verify the K-number directly on FDA.gov?
  3. Does the vendor serve only the provider side, or does it also offer a payer-facing claims product?
  4. Which practice management and imaging systems does it integrate with, by name, not just "PMS-agnostic"?
  5. What is the published price, and does it change with patient volume or number of locations?
  6. Is the review score you are looking at for the exact product being pitched, or for a related product from the same company?
  7. Is the review platform a customer-review site (G2, Capterra) or an employee-review site (Glassdoor), and are you comparing the right kind?
  8. Who funded the company, how much, and how recently, as a proxy for its staying power?
  9. Is the vendor an independent company, or does its FDA clearance depend on another vendor's device as a predicate?
  10. What does the vendor claim for accuracy or time savings, and is that claim from an independent study or the vendor's own marketing?
  11. Does the tool address your actual clinical workflow (2D chairside, 3D CBCT, ortho monitoring, cephalometric analysis) or a different one entirely?
  12. If pricing is not published, what is the actual quote you receive after a demo, and how does it compare across at least two vendors on this list?

How Needletail Approaches This

Needletail AI does not compete in the AI-powered imaging category covered by this comparison; its platform focuses on eligibility and benefits verification. For that adjacent workflow, see Needletail's eligibility and benefits verification service, or open the interactive demo to see a live verification run against a real payer portal.

About the Author

Georgey Jacob writes on dental industry structure for PipeRocket Digital, covering how dental AI, imaging, billing, and credentialing vendors are actually organized, funded, and regulated, so that practices and DSOs can evaluate them past the marketing copy.

About the Author

Georgey Jacob

Georgey Jacob

Head of Growth, Needletail AI

Georgey Jacob is the Head of Growth at Needletail AI, leading go-to-market strategy for the company's dental DSO and group practice segment. He previously served as Head of Growth at MoveInSync, where he led international GTM strategies across paid media, SEO, and account-based marketing. He brings over 8 years of experience in data-driven B2B growth.

Frequently Asked Questions

Get Started Today

Still fighting eligibility fires?
Ready to stop?

See how Needletail verifies tomorrow's patients before your team clocks in

Dental office professional with AI-powered smart glasses